| Code | 3983A | ||||||||||
| MA number | 44/0025/13-S | ||||||||||
| Product Form: | tbl flm 60(6x10)x150 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 31.01.2013 |
| PIL: |
PIL_Capecitabine Pharmagen 150 mg_04/2021.pdf
|
| SPC: |
SPC_Capecitabine Pharmagen 150 mg_04/2021.pdf
|
| Safety feature | Yes |
| Data update: | 08.02.2019 |
